CHICAGO (WLS) -- After the FDA approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods, sufferers say they're ...
The drug does not completely prevent reactions, but it can reduce the risks posed by trace amounts of food allergens. By Roni Caryn Rabin The Food and Drug Administration approved a drug this month ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Two weeks ago, the Food and Drug Administration approved Xolair ...
Findings showed that compared with placebo, Xolair significantly increased the amount of peanut, milk, egg, and cashew participants could consume without an allergic reaction. The Food and Drug ...
If you have food allergies, you know the dread: You'll be at a gathering and no one can tell you for sure if there are peanuts or eggs in any of the food. So you take a risk or you don't eat. Now, a ...
The FDA's approval of the new dosing option for Omlyclo addresses the diverse needs of patients with allergic and inflammatory conditions. "The approval of the additional 300 mg presentation of Omlyco ...
That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...
Xolair is a branded injectable medication used to treat allergic asthma, chronic hives, and rhinosinusitis. It’s recently been approved to manage food allergies, reducing the risk of serious reactions ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new positive data from Stage 2 and Stage 3 of the National Institutes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results